[EN] COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4<br/>[FR] COMPOSES INHIBANT L'ADHESION AUX LEUCOCYTES A MEDIATION ASSUREE PAR VLA-4
申请人:ELAN PHARM INC
公开号:WO2000043369A1
公开(公告)日:2000-07-27
Disclosed are compounds (Ia or Ib) which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthiritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.